By targeting sirt1, miR-543 promoted the progression of gastric cancer [21], whereas in endometrial cancer, miR-543 acts as a tumor suppressor by decreasing the levels of FAK and TWIST1 [22]. This evidence concerns the gene SIRT1 and gastric cancer.